Depo-medrol Injection, Suspension
Product Images NDC 0009-0306
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Depo-medrol (NDC 0009-0306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Depo Medrol 02)
Principal Display Panel (100 mg/5 mL Vial Label)
This is a medication called Depo-Medrol, which is a injectable suspension containing 100mg of methylPREDNISolone acetate per 5mL multidose vial. It is not for IV use but can be used for intrasynovial and soft tissue injections. It contains benzyl alcohol as a preservative. The dosage and use information can be found in the accompanying prescribing information and the product is distributed by Pharmacia & Upjohn Co within Pfizer Inc., located in New York City.*
Principal Display Panel (100 mg/5 mL Vial Carton)
Depo-Medrol is a type of injectable corticosteroid that is used to treat a variety of conditions such as arthritis, allergies, and skin conditions. It is available in a multidose vial and contains methylprednisolone acetate in a suspension form. It is important to store the medication at a controlled room temperature and shake well before use. The medication is only for intramuscular, intrasynovial, and soft tissue injection only and should not be used intravenously. It contains benzyl alcohol as a preservative. This medication is manufactured by Phamacia & Upiohn Co., a division of Pfizer Inc.*
Principal Display Panel (200 mg/5 mL Vial Label)
This is a description of a Multi-dose Vial for injection into intra-synovial and soft tissue areas, but not for IV use, that contains Benzyl Alcohol as a preservative. It contains injectable suspension called methyl olone acetate and is distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc, New York. The vial has a concentration of 40mg/ml and is to be shaken well before immediate use.*
Principal Display Panel (200 mg/5 mL Vial Package)
Depo-Nedrol is a brand name of a type of injectable suspension composed of methylprednisolone acetate, a type of corticosteroid. The suspension contains 200 mg of the medication in 5 mL of solution, resulting in a concentration of 40 mg/mL. The specific solution evaluated in the text has a National Drug Code of 570009-0280-51 2. The suspension should be kept at a specific temperature range of 20 to 25 degrees Celsius.*
Principal Display Panel (400 mg/5 mL Vial Label)
This is a medication called Depo-MedrolĀ® with a concentration of 80mg/mL of methylPREDNISolone acetate. It is intended for intrasynovial and soft tissue injection only and should not be used intravenously. The medication contains Benzyl Alcohol as a preservative. The recommended dosage and use can be found in the accompanying prescribing information, and the vial should be shaken well before use. The medication is distributed by Pharmacia & Upjohn Co, a Division of Pfizer Inc, and is packaged in a 5 mL multidose vial. Prescription required.*
Principal Display Panel (400 mg/5 mL Vial Carton)
This is a description of a medication called "Depo-MedrolĀ®" which is a methylprednisolone acetate injectable suspension. The medication comes in a 5mL multidose vial with a concentration of 80 mg/mL. The medication is for intramuscular, intrasynovial and soft tissue injection only and should not be used for IV purposes. The vial contains benzyl alcohol as a preservative. The dosage and use information for the medication is included in an accompanying prescribing information. The medication is manufactured by Pharmacia & Upjohn Co., a division of Pfizer Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.